These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34112717)

  • 1. N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis.
    Stunnenberg BC; Merkus EC; Raaphorst J; Saris CG; Groenewoud H; Statland J; Weijma R; van Vlijmen B; Griggs R; van Engelen BGM; van der Wilt GJ
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1352-1353. PubMed ID: 34112717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Favorable results of the treatment of the hyperkalemic form of periodic paralysis with salbutamol].
    Rysz A; Emeryk B
    Neurol Neurochir Pol; 1985; 19(5):444-7. PubMed ID: 2421192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A).
    Hanna MG; Stewart J; Schapira AH; Wood NW; Morgan-Hughes JA; Murray NM
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):248-50. PubMed ID: 9703181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalaemic periodic paralysis in pregnancy.
    Yong SL; Sin TH; Tang EB; Chai MC
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment: Salbutamol--A means to an endplate.
    Wolfe GI; Silvestri NJ
    Neurology; 2016 Feb; 86(7):693. PubMed ID: 26791151
    [No Abstract]   [Full Text] [Related]  

  • 6. Salbutamol-responsive fetal acetylcholine receptor inactivation syndrome.
    Allen NM; Hacohen Y; Palace J; Beeson D; Vincent A; Jungbluth H
    Neurology; 2016 Feb; 86(7):692-4. PubMed ID: 26791147
    [No Abstract]   [Full Text] [Related]  

  • 7. Salbutamol Therapy for Food Impaction in Eosinophilic Oesophagitis.
    Dias JA; Fernandes S; Corujeira S; Trindade E; Tavares M; Murch S
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):e97. PubMed ID: 28628545
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Salbutamol in hyperkalaemic familial periodic paralysis.
    Harris DM
    Lancet; 1976 Feb; 1(7956):427. PubMed ID: 55692
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of enteral salbutamol in spinal shock.
    Llompart-Pou JA; Pericàs-Pulido P; Pérez-Bárcena J; Raurich JM
    Med Intensiva; 2016; 40(5):315-6. PubMed ID: 26748957
    [No Abstract]   [Full Text] [Related]  

  • 10. COLQ-Related Congenital Myasthenic Syndrome and Response to Salbutamol Therapy.
    Padmanabha H; Saini AG; Sankhyan N; Singhi P
    J Clin Neuromuscul Dis; 2017 Mar; 18(3):162-163. PubMed ID: 28221310
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol.
    Wang P; Clausen T
    Lancet; 1976 Jan; 1(7953):221-3. PubMed ID: 55532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous salbutamol for childhood asthma: evidence-based medicine?
    Starkey ES; Mulla H; Sammons HM; Pandya HC
    Arch Dis Child; 2014 Sep; 99(9):873-7. PubMed ID: 24938536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of albuterol in patients with prior second trimester spontaneous abortion related to uterine anomaly.
    Al-Chalabi KA
    Int J Gynaecol Obstet; 2012 May; 117(2):184-5. PubMed ID: 22342052
    [No Abstract]   [Full Text] [Related]  

  • 14. Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.
    Tiziano FD; Lomastro R; Abiusi E; Pasanisi MB; Di Pietro L; Fiori S; Baranello G; Angelini C; Sorarù G; Gaiani A; Mongini T; Vercelli L; Mercuri E; Vasco G; Pane M; Vita G; Vita G; Messina S; Petillo R; Passamano L; Politano L; Campanella A; Mantegazza R; Morandi L
    J Med Genet; 2019 May; 56(5):293-300. PubMed ID: 30593463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol.
    Radice S; Milanesi A; Antoniazzi S; Perrone V; Carnovale C; Clementi E
    Eur J Clin Pharmacol; 2011 Nov; 67(11):1203-4. PubMed ID: 21638032
    [No Abstract]   [Full Text] [Related]  

  • 16. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
    Patel M; Thomson NC
    Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.
    Lorenzoni PJ; Scola RH; Kay CS; Filla L; Miranda AP; Pinheiro JM; Chaouch A; Lochmüller H; Werneck LC
    J Neurol Sci; 2013 Aug; 331(1-2):155-7. PubMed ID: 23790237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial.
    Motazedian S; Ghaffarpasand F; Mojtahedi K; Asadi N
    Ann Saudi Med; 2010; 30(5):370-5. PubMed ID: 20697169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population.
    Bandaru S; Tarigopula P; Akka J; Marri VK; Kattamuri RK; Nayarisseri A; Mangalarapu M; Vinukonda S; Mundluru HP; Sagurthi SR
    Gene; 2016 Oct; 592(1):15-22. PubMed ID: 27450915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).
    Makhlouf K; Weiner HL; Khoury SJ
    CNS Drugs; 2002; 16(1):1-8. PubMed ID: 11772115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.